2020-02-06 10:04
本条微博链接
Patient First! Gilead CEO’s response to patent issue: “I think my message to you and everybody is that has no impact on what we are going to do with global health. I just want to be tremendously clear here that our responsibility is the patients. And our responsibility is number one: pursue the right clinical programs to determine whether or not this medicine has impact with patients or not, and it'll be driven by the science, by the clinical evidence. And at the same time, ramping our production up, in the event that it does, we can get
………………………………